A clinical trial has found evidence that the experimental drug tofersen lowers levels of a disease-causing protein in people with an inherited form of amyotrophic lateral sclerosis, or ALS, caused by mutations in the gene SOD1.
from Latest Science News -- ScienceDaily https://ift.tt/2VZTQDU
Related Posts :
Turning diamond into metalResearchers have discovered a way to tweak tiny needles of diamond in a controlled way to transform their electronic properties, dialing the… ...- Nobel Prize in Physiology or Medicine 2020: Discovery of Hepatitis C virusThe 2020 Nobel Prize in Physiology or Medicine is being awarded jointly to Harvey J. Alter, Michael Houghton and Charles M. Rice for the dis… ...
- Dog brains do not prefer facesEven though dogs gaze into man's eyes, dog brains may not process faces as human brains do. A new study suggests that the canine visual syst… ...
- Trans-Neptunian object Arrokoth: Flattening of a snowmanThe trans-Neptunian object Arrokoth, also known as Ultima Thule, which NASA's space probe New Horizons passed on New Year's Day 2019, may ha… ...
- 'Like a fishing net,' nanonet collapses to trap drug moleculesResearchers have discovered a new, rapid method for fabricating nanoparticles from a simple, self-assembling polymer, which present new poss… ...
0 Response to "Experimental drug shows early promise against inherited form of ALS, trial indicates"
Post a Comment